Intermediate stage hepatoceullular carcinoma research hub

A study to test whether adding nivolumab to TACE/TAE treatment is effective and safe in patients with intermediate-stage liver cancer

This clinical trial looks at a treatment for intermediate-stage liver cancer. Researchers are testing whether combining standard liver chemoembolisation (TACE) with an immunotherapy drug called nivolumab works better than chemoembolisation alone. The aim is to see if this combination safely helps control tumour growth for longer.